NIFTY 50 23024.65 ▼ (1.37%)
NIFTY NEXT 50 63406.15 ▼ (2.61%)
NIFTY 100 23664.75 ▼ (1.6%)
NIFTY MIDCAP 100 53834.95 ▼ (2.31%)
NIFTY SMALLCAP 100 17456.5 ▼ (2.28%)
NIFTY SMALLCAP 250 16484.1 ▼ (2.12%)
NIFTY MIDCAP SELECT 12013.35 ▼ (2.78%)
NIFTY TOTAL MARKET 12091.55 ▼ (1.73%)
NIFTY BANK 48570.9 ▼ (1.58%)
SENSEX 75838.36 ▼ (1.6%)
BSE BANKEX 55020.92 ▼ (1.81%)

JOHNSON PHARMACARE announced Financial Results Q1 2024-25

August 31, 2024August 31, 2024| adminadmin| 0 Comments| 9:45 pm
Image is loading
Categories:

Share the post "JOHNSON PHARMACARE announced Financial Results Q1 2024-25"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

  • The presented financial data is Standalone to provide a comprehensive overview of the company performance.
  • Profit over the Year and quarter: Challenges in sustaining profitability for JOHNSON PHARMACARE LIMITED. Profit dropped by -78.72 % Year to Year, JOHNSON PHARMACARE LIMITED’s profitability increased by 1900 % in this quarter.
  • EPS over the Year and quarter:

The comprehensive analytics outlining the performance and outlook of JOHNSON PHARMACARE LIMITED‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Expenses Rs. 0.19 Cr Rs. 0 Cr Rs. 0.04 Cr 0 % -78.95 %
Operating Profit Rs. -0.19 Cr Rs. 0 Cr Rs. -0.04 Cr 0 % + 78.95 %
OPM % 0 % 0 % 0 % 0 % 0 %
Other Income Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Interest Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Depreciation Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Profit before tax Rs. -0.19 Cr Rs. 0 Cr Rs. -0.04 Cr 0 % + 78.95 %
Tax % -0 % -0 % -0 % 0 % 0 %
Net Profit Rs. -0.19 Cr Rs. -0 Cr Rs. -0.04 Cr 0 % + 78.95 %
EPS in Rs Rs. 0 Rs. 0 Rs. 0 0 % 0 %


Today, we’re looking at JOHNSON PHARMACARE LIMITED’s financial performance for the Q1(Jun 2024).aligning with the annual decline of -78.95 %. Operating profit, while up 78.95 % compared to last year,
Profit before tax grew annually by 78.95 %
Net profit rose by 78.95 % year-on-year In summary, JOHNSON PHARMACARE LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Expenses Rs. 0.19 Cr Rs. 0 Cr Rs. 0.04 Cr 0 % -78.95 %
Operating Profit Rs. -0.19 Cr Rs. 0 Cr Rs. -0.04 Cr 0 % + 78.95 %
Net Profit Rs. -0.19 Cr Rs. -0 Cr Rs. -0.04 Cr 0 % + 78.95 %
EPS in Rs Rs. 0 Rs. 0 Rs. 0 0 % 0 %


In reviewing JOHNSON PHARMACARE LIMITED’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Expenses decreased by -78.95 % compared to the previous year, Operating Profit surged by 78.95 % annually,
Net Profit showed yearly increase of 78.95 %, In essence, while JOHNSON PHARMACARE LIMITED faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”JOHNSON PHARMACARE “]

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post